Improved survival in primary central nervous system lymphoma up to age 70 only: a population-based study on incidence, primary treatment and survival in the Netherlands, 1989-2015

Leukemia. 2017 Aug;31(8):1822-1825. doi: 10.1038/leu.2017.128. Epub 2017 Apr 28.
No abstract available

Publication types

  • Letter

MeSH terms

  • Adolescent
  • Adult
  • Aged
  • Antineoplastic Agents / therapeutic use
  • Central Nervous System Neoplasms / mortality*
  • Central Nervous System Neoplasms / pathology
  • Central Nervous System Neoplasms / therapy*
  • Chemoradiotherapy
  • Female
  • Humans
  • Incidence
  • Lymphoma, Large B-Cell, Diffuse / mortality*
  • Lymphoma, Large B-Cell, Diffuse / pathology
  • Lymphoma, Large B-Cell, Diffuse / therapy*
  • Male
  • Middle Aged
  • Netherlands / epidemiology
  • Radiotherapy
  • Survival Analysis
  • Young Adult

Substances

  • Antineoplastic Agents